BACKGROUND: The study used a set of 407 human extraintestinal pathogenic E. coli strains (ExPEC) isolated from (1) skin and soft tissue infections, (2) respiratory infections, (3) intra-abdominal infections, and (4) genital smears. The set was tested for bacteriocin production, for prevalence of bacteriocin and virulence determinants, and for phylogenetic typing. Results obtained from the group of ExPEC strains were compared to data from our previously published analyses of 1283 fecal commensal E. coli strains. RESULTS: The frequency of bacteriocinogeny was significantly higher in the set of ExPEC strains (63.1 %), compared to fecal E. coli (54.2 %; p < 0.01). Microcin producers and microcin determinants dominated in ExPEC strains, while colicin producers and colicin determinants were more frequent in fecal E. coli (p < 0.01). Higher production of microcin M and lower production of microcin B17, colicin Ib, and Js was detected in the set of ExPEC strains. ExPEC strains had a significantly higher prevalence of phylogenetic group B2 (52.6 %) compared to fecal E. coli strains (38.3 %; p < 0.01). CONCLUSIONS: Human ExPEC strains were shown to differ from human fecal strains in a number of parameters including bacteriocin production, prevalence of several bacteriocin and virulence determinants, and prevalence of phylogenetic groups. Differences in these parameters were also identified within subgroups of ExPEC strains of diverse origin. While some microcin determinants (mM, mH47) were associated with virulent strains, other bacteriocin types (mB17, Ib, and Js) were associated with fecal flora.

Department of Biology Faculty of Medicine Masaryk University Kamenice 5 Building A6 625 00 Brno Czech Republic

Department of Clinical Microbiology Faculty Hospital Brno Jihlavská 20 625 00 Brno Czech Republic

See more in PubMed

Orskov I, Orskov F. Escherichia coli in extra-intestinal infections. J Hyg (Lond) 1985;95:551–75. doi: 10.1017/S0022172400060678. PubMed DOI PMC

Eisenstein BI, Jones GW. The spectrum of infections and pathogenic mechanisms of Escherichia coli. Adv Intern Med. 1988;33:231–52. PubMed

Rasko DA, Rosovitz MJ, Myers GS, Mongodin EF, Fricke WF, Gajer P, Crabtree J, Sebaihia M, Thomson NR, Chaudhuri R, Henderson IR, Sperandio V, Ravel J. The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates. J Bacteriol. 2008;190:6881–93. doi: 10.1128/JB.00619-08. PubMed DOI PMC

Johnson JR, Russo TA. Extraintestinal pathogenic Escherichia coli: “the other bad E. coli”. J Lab Clin Med. 2002;139:155–62. doi: 10.1067/mlc.2002.121550. PubMed DOI

Leffler H, Svanborg-Edén C. Glycolipid receptors for uropathogenic Escherichia coli on human erythrocytes and uroepithelial cells. Infect Immun. 1981;34:920–9. PubMed PMC

Mulvey MA. Adhesion and entry of uropathogenic Escherichia coli. Cell Microbiol. 2002;4:257–71. doi: 10.1046/j.1462-5822.2002.00193.x. PubMed DOI

Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev. 1991;4:80–128. doi: 10.1128/CMR.4.1.80. PubMed DOI PMC

Šmarda J, Šmajs D. Colicins - exocellular lethal proteins of Escherichia coli. Folia Microbiol (Praha) 1998;43:563–82. doi: 10.1007/BF02816372. PubMed DOI

Cascales E, Buchanan SK, Duché D, Kleanthous C, Lloubès R, Postle K, Riley M, Slatin S, Cavard D. Colicin biology. Microbiol Mol Biol Rev MMBR. 2007;71:158–229. doi: 10.1128/MMBR.00036-06. PubMed DOI PMC

Azpiroz MF, Poey ME, Laviña M. Microcins and urovirulence in Escherichia coli. Microb Pathog. 2009;47:274–80. doi: 10.1016/j.micpath.2009.09.003. PubMed DOI

Šmajs D, Micenková L, Šmarda J, Vrba M, Ševčíková A, Vališová Z, Woznicová V. Bacteriocin synthesis in uropathogenic and commensal Escherichia coli: colicin E1 is a potential virulence factor. BMC Microbiol. 2010;10:288. doi: 10.1186/1471-2180-10-288. PubMed DOI PMC

Budič M, Rijavec M, Petkovšek Z, Zgur-Bertok D. Escherichia coli bacteriocins: antimicrobial efficacy and prevalence among isolates from patients with bacteraemia. PLoS One. 2011;6:e28769. doi: 10.1371/journal.pone.0028769. PubMed DOI PMC

Šmajs D, Weinstock GM. Genetic organization of plasmid ColJs, encoding colicin Js activity, immunity, and release genes. J Bacteriol. 2001;183:3949–57. doi: 10.1128/JB.183.13.3949-3957.2001. PubMed DOI PMC

Šmajs D, Weinstock GM. The iron- and temperature-regulated cjrBC genes of Shigella and enteroinvasive Escherichia coli strains code for colicin Js uptake. J Bacteriol. 2001;183:3958–66. doi: 10.1128/JB.183.13.3958-3966.2001. PubMed DOI PMC

Riley MA, Gordon DM. The ecological role of bacteriocins in bacterial competition. Trends Microbiol. 1999;7:129–33. doi: 10.1016/S0966-842X(99)01459-6. PubMed DOI

Cornut G, Fortin C, Soulières D. Antineoplastic properties of bacteriocins: revisiting potential active agents. Am J Clin Oncol. 2008;31:399–404. doi: 10.1097/COC.0b013e31815e456d. PubMed DOI

Micenková L, Štaudová B, Bosák J, Mikalová L, Littnerová S, Vrba M, Ševčíková A, Woznicová V, Šmajs D. Bacteriocin-encoding genes and ExPEC virulence determinants are associated in human fecal Escherichia coli strains. BMC Microbiol. 2014;14:109. doi: 10.1186/1471-2180-14-109. PubMed DOI PMC

Davies DL, Falkiner FR, Hardy KG. Colicin V production by clinical isolates of Escherichia coli. Infect Immun. 1981;31:574–9. PubMed PMC

Kohoutová D, Šmajs D, Moravková P, Cyrany J, Moravková M, Forstlová M, Čihák M, Rejchrt S, Bureš J. Escherichia coli strains of phylogenetic group B2 and D and bacteriocin production are associated with advanced colorectal neoplasia. BMC Infect Dis. 2014;14:733. doi: 10.1186/s12879-014-0733-7. PubMed DOI PMC

Micenková L, Bosák J, Štaudová B, Kohoutová D, Čejková D, Woznicová V, Vrba M, Ševčíková A, Bureš J, Šmajs D. Microcin determinants are associated with B2 phylogroup of human fecal Escherichia coli isolates. Microbiol Open. 2016 PubMed PMC

Mokady D, Gophna U, Ron EZ. Virulence factors of septicemic Escherichia coli strains. Int J Med Microbiol. 2005;295:455–62. doi: 10.1016/j.ijmm.2005.07.007. PubMed DOI

Petkovsek Z, Elersic K, Gubina M, Zgur-Bertok D, Starcic Erjavec M. Virulence potential of Escherichia coli isolates from skin and soft tissue infections. J Clin Microbiol. 2009;47:1811–7. doi: 10.1128/JCM.01421-08. PubMed DOI PMC

Köhler CD, Dobrindt U. What defines extraintestinal pathogenic Escherichia coli? Int J Med Microbiol. 2011;301:642–7. doi: 10.1016/j.ijmm.2011.09.006. PubMed DOI

Fakruddin M, Mazumdar RM, Chowdhury A, Mannan KS. A preliminary study on virulence factors & antimicrobial resistance in extra-intestinal pathogenic Escherichia coli (ExPEC) in Bangladesh. Indian J Med Res. 2013;137:988–90. PubMed PMC

Koga VL, Tomazetto G, Cyoia PS, Neves MS, Vidotto MC, Nakazato G, Kobayashi RK. Molecular screening of virulence genes in extraintestinal pathogenic Escherichia coli isolated from human blood culture in Brazil. Biomed Res Int. 2014;2014:465054. doi: 10.1155/2014/465054. PubMed DOI PMC

Picard B, Garcia JS, Gouriou S, Duriez P, Brahimi N, Bingen E, Elion J, Denamur E. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun. 1999;67:546–53. PubMed PMC

Santos AC, Zidko AC, Pignatari AC, Silva RM. Assessing the diversity of the virulence potential of Escherichia coli isolated from bacteremia in São Paulo, Brazil. Braz J Med Biol Res. 2013;46:968–73. doi: 10.1590/1414-431X20133184. PubMed DOI PMC

Mirzarazi M, Rezatofighi SE, Pourmahdi M, Mohajeri MR. Occurrence of genes encoding enterotoxins in uropathogenic Escherichia coli isolates. Braz J Microbiol. 2015;46:155–9. doi: 10.1590/S1517-838246120130860. PubMed DOI PMC

Chakraborty A, Saralaya V, Adhikari P, Shenoy S, Baliga S, Hegde A. Characterization of Escherichia coli Phylogenetic Groups Associated with Extraintestinal Infections in South Indian Population. Indian J Pathol Microbiol. 2014;57:255–8. doi: 10.4103/0377-4929.134700. PubMed DOI PMC

Waters VL, Crosa JH. Colicin V virulence plasmids. Microbiol Rev. 1991;55:437–50. PubMed PMC

Duquesne S, Destoumieux-Garzón D, Peduzzi J, Rebuffat S. Microcins, gene-encoded antibacterial peptides from enterobacteria. Nat Prod Rep. 2007;24:708–34. doi: 10.1039/b516237h. PubMed DOI

Jeziorowski A, Gordon DM. Evolution of microcin V and colicin Ia plasmids in Escherichia coli. J Bacteriol. 2007;189:7045–52. doi: 10.1128/JB.00243-07. PubMed DOI PMC

Šmajs D, Strouhal M, Matějková P, Čejková D, Cursino L, Chartone-Souza E, Šmarda J, Nascimento AM. Complete sequence of low-copy-number plasmid MccC7-H22 of probiotic Escherichia coli H22 and the prevalence of mcc genes among human E. coli. Plasmid. 2008;59:1–10. doi: 10.1016/j.plasmid.2007.08.002. PubMed DOI

Gordon DM, O’Brien CL. Bacteriocin diversity and the frequency of multiple bacteriocin production in Escherichia coli. Microbiology. 2006;152:3239–44. doi: 10.1099/mic.0.28690-0. PubMed DOI

Nielsen KL, Dynesen P, Larsen P, Frimodt-Møller N. Faecal Escherichia coli from patients with E. coli urinary tract infection and healthy controls who have never had a urinary tract infection. J Med Microbiol. 2014;63:582–9. doi: 10.1099/jmm.0.068783-0. PubMed DOI

Moreno E, Andreu A, Pigrau C, Kuskowski MA, Johnson JR, Prats G. Relationship between Escherichia coli strains causing acute cystitis in women and the fecal E. coli population of the host. J Clin Microbiol. 2008;46:2529–34. doi: 10.1128/JCM.00813-08. PubMed DOI PMC

Micenková L, Šišková P, Bosák J, Jamborová I, Černohorská L, Šmajs D. Characterization of human uropathogenic ESBL-producing Escherichia coli in the Czech Republic: spread of CTX-M-27-producing strains in a university hospital. Microb Drug Resist. 2014;20:610–7. doi: 10.1089/mdr.2014.0013. PubMed DOI

Patzer SI, Baquero MR, Bravo D, Moreno F, Hantke K. The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN. Microbiology (Reading, Engl) 2003;149:2557–70. doi: 10.1099/mic.0.26396-0. PubMed DOI

Martínez JL, Herrero M, de Lorenzo V. The organization of intercistronic regions of the aerobactin operon of pColV-K30 may account for the differential expression of the iucABCD iutA genes. J Mol Biol. 1994;238:288–93. doi: 10.1006/jmbi.1994.1290. PubMed DOI

Schmidt H, Knop C, Franke S, Aleksic S, Heesemann J, Karch H. Development of PCR for screening of enteroaggregative Escherichia coli. J Clin Microbiol. 1995;33:701–5. PubMed PMC

Yamamoto S, Terai A, Yuri K, Kurazono H, Takeda Y, Yoshida O. Detection of urovirulence factors in Escherichia coli by multiplex polymerase chain reaction. FEMS Immunol Med Microbiol. 1995;12:85–90. doi: 10.1111/j.1574-695X.1995.tb00179.x. PubMed DOI

Kuhnert P, Hacker J, Mühldorfer I, Burnens AP, Nicolet J, Frey J. Detection system for Escherichia coli-specific virulence genes: absence of virulence determinants in B and C strains. Appl Environ Microbiol. 1997;63:703–9. PubMed PMC

Paton AW, Paton JC. Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stx1, stx2, eaeA, enterohemorrhagic E. coli hlyA, rfbO111, and rfbO157. J Clin Microbiol. 1998;36:598–602. PubMed PMC

Paciorek J. Virulence properties of Escherichia coli faecal strains isolated in Poland from healthy children and strains belonging to serogroups O18, O26, O44, O86, O126 and O127 isolated from children with diarrhoea. J Med Microbiol. 2002;51:548–56. doi: 10.1099/0022-1317-51-7-548. PubMed DOI

López-Saucedo C, Cerna JF, Villegas-Sepulveda N, Thompson R, Velazquez FR, Torres J, Tarr PI, Estrada-García T. Single multiplex polymerase chain reaction to detect diverse loci associated with diarrheagenic Escherichia coli. Emerging Infect Dis. 2003;9:127–31. doi: 10.3201/eid0901.010507. PubMed DOI PMC

Bírošová E, Siegfried L, Kmeťová M, Makara A, Ostró A, Gresová A, Urdzík P, Liptáková A, Molokácová M, Bártl R, Valanský L. Detection of virulence factors in alpha-haemolytic Escherichia coli strains isolated from various clinical materials. Clin Microbiol Infect. 2004;10:569–73. doi: 10.1111/j.1469-0691.2004.00922.x. PubMed DOI

Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol. 2000;66:4555–8. doi: 10.1128/AEM.66.10.4555-4558.2000. PubMed DOI PMC

Escherichia coli from biopsies differ in virulence genes between patients with colorectal neoplasia and healthy controls

Escherichia coli Strains Producing Selected Bacteriocins Inhibit Porcine Enterotoxigenic Escherichia coli (ETEC) under both In Vitro and In Vivo Conditions

Colicin U from Shigella boydii Forms Voltage-Dependent Pores

Colicin Z, a structurally and functionally novel colicin type that selectively kills enteroinvasive Escherichia coli and Shigella strains

Colicin FY inhibits pathogenic Yersinia enterocolitica in mice

Characterization of four Escherichia albertii isolates collected from animals living in Antarctica and Patagonia